A nurse is caring for a client who is receiving vancomycin by IV infusion over 30 min. Which of the following findings indicate the clien experiencing a vancomycin infusion reaction?

A) Pain level: Assessing the client's pain level may be important for administering analgesic medications, but it is not directly related to the administration of propranolol. Propranolol is a beta-blocker primarily used to treat conditions such as hypertension, angina, and certain cardiac arrhythmias, so assessing pain level is not the priority.

B) Respiratory rate: While monitoring respiratory rate is important in various clinical situations, propranolol administration does not typically have a direct effect on respiratory function. Therefore, assessing the respiratory rate specifically before administering propranolol may not be as relevant as other vital signs.

C) Heart rate: Propranolol is a beta-blocker that primarily works by slowing the heart rate and reducing the workload on the heart. Therefore, it is crucial for the nurse to assess the client's heart rate prior to administering propranolol to ensure it is within the appropriate range. Administering propranolol to a client with bradycardia or a significantly low heart rate could exacerbate this condition and lead to adverse effects.

D) Temperature: While monitoring temperature is important for assessing for signs of infection or other systemic issues, it is not directly relevant to the administration of propranolol. Propranolol primarily affects cardiovascular function, so assessing temperature is not typically a priority before administering this medication

) Glaucoma: Atropine is contraindicated in clients with glaucoma due to its potential to exacerbate intraocular pressure. Glaucoma is a condition characterized by increased intraocular pressure, which can lead to optic nerve damage and vision loss if left untreated or if pressure is further increased. Atropine, as an anticholinergic medication, works by dilating the pupil and inhibiting accommodation, thereby increasing intraocular pressure. Administering atropine to a client with glaucoma can worsen their condition and potentially cause acute angle-closure glaucoma, which is a medical emergency. Therefore, it is essential to avoid using atropine in clients with glaucoma to prevent irreversible vision loss and other serious complications.

B) Bronchospasms: Atropine can be used to treat bronchospasms by dilating the bronchi and bronchioles, making it easier to breathe. While it may not be the first-line treatment for bronchospasms, it is not contraindicated in this condition. The bronchodilatory effects of atropine help relieve airway constriction and improve airflow, which can be beneficial in managing bronchospasms associated with conditions such as asthma or chronic obstructive pulmonary disease (COPD). Therefore, atropine can be considered as part of the treatment regimen for bronchospasms when indicated.

C) Diverticulitis: Atropine does not have any specific contraindications related to diverticulitis. However, caution should be exercised in clients with pre-existing gastrointestinal conditions due to potential anticholinergic effects, such as decreased gastrointestinal motility. While atropine can inhibit gastrointestinal motility and secretions, which may exacerbate symptoms in some individuals with diverticulitis, it is not considered a contraindication. The decision to use atropine in clients with diverticulitis should be based on the overall assessment of the client's condition and the potential benefits versus risks of treatment.

D) Diarrhea: Atropine can be used to treat diarrhea by reducing gastrointestinal motility and secretions. Therefore, it is not contraindicated in clients with diarrhea. By slowing down gastrointestinal motility and reducing secretions, atropine can help alleviate diarrhea and promote better bowel control. While other treatment options may be considered depending on the underlying cause of diarrhea, atropine can be effective in managing diarrhea associated with certain conditions or as part of a treatment regimen for specific gastrointestinal disorders.